CD73: Friend or Foe in Lung Injury
Open Access
- 14 March 2023
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (6) , 5545
Abstract
Ecto-5′-nucleotidase (CD73) plays a strategic role in calibrating the magnitude and chemical nature of purinergic signals that are delivered to immune cells. Its primary function is to convert extracellular ATP to adenosine in concert with ectonucleoside triphosphate diphosphohydrolase-1 (CD39) in normal tissues to limit an excessive immune response in many pathophysiological events, such as lung injury induced by a variety of contributing factors. Multiple lines of evidence suggest that the location of CD73, in proximity to adenosine receptor subtypes, indirectly determines its positive or negative effect in a variety of organs and tissues and that its action is affected by the transfer of nucleoside to subtype-specific adenosine receptors. Nonetheless, the bidirectional nature of CD73 as an emerging immune checkpoint in the pathogenesis of lung injury is still unknown. In this review, we explore the relationship between CD73 and the onset and progression of lung injury, highlighting the potential value of this molecule as a drug target for the treatment of pulmonary disease.Keywords
Funding Information
- National Natural Science Foundation of China (82104491, 2023NSFSC0674, 2022NSFSC0854, 2021M693789, 2019YFC1709101)
- Natural Science Foundation of Sichuan Province (82104491, 2023NSFSC0674, 2022NSFSC0854, 2021M693789, 2019YFC1709101)
- Postdoctoral Science Foundation of China (82104491, 2023NSFSC0674, 2022NSFSC0854, 2021M693789, 2019YFC1709101)
- National Key R&D Program of China (82104491, 2023NSFSC0674, 2022NSFSC0854, 2021M693789, 2019YFC1709101)
This publication has 119 references indexed in Scilit:
- CD39 and CD73 in immunity and inflammationTrends in Molecular Medicine, 2013
- CD73: a potent suppressor of antitumor immune responsesTrends in Immunology, 2012
- Altered purinergic signaling in CD73‐deficient mice inhibits tumor progressionEuropean Journal of Immunology, 2011
- Anti-CD73 antibody therapy inhibits breast tumor growth and metastasisProceedings of the National Academy of Sciences, 2010
- Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascadeBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2008
- Adenosine receptors and asthmaBritish Journal of Pharmacology, 2008
- IFN‐β protects from vascular leakage via up‐regulation of CD73European Journal of Immunology, 2007
- Physiological roles for ecto-5’-nucleotidase (CD73)Purinergic Signalling, 2006
- Ecto-5’-nucleotidase: Structure function relationshipsPurinergic Signalling, 2006
- Ecto‐enzyme and signaling functions of lymphocyte CD 7 3Immunological Reviews, 1998